Cindy Jacobs

2021

In 2021, Cindy Jacobs earned a total compensation of $1.1M as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 37% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$228,800
Option Awards$324,141
Salary$440,000
Stock Awards$65,450
Total$1,058,391

Jacobs received $440K in salary, accounting for 42% of the total pay in 2021.

Jacobs also received $228.8K in non-equity incentive plan, $324.1K in option awards and $65.5K in stock awards.

Rankings

In 2021, Cindy Jacobs' compensation ranked 8,610th out of 12,415 executives tracked by ExecPay. In other words, Jacobs earned more than 30.6% of executives.

ClassificationRankingPercentile
All
8,610
out of 12,415
31st
Division
Manufacturing
3,816
out of 5,505
31st
Major group
Chemicals And Allied Products
1,689
out of 2,375
29th
Industry group
Drugs
1,503
out of 2,096
28th
Industry
In Vitro and In Vivo Diagnostic Substances
35
out of 61
43rd
Source: SEC filing on April 21, 2022.

Jacobs' colleagues

We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2021.

2021

John Bencich

OncoGenex Pharmaceuticals

Chief Executive Officer

2021

Richard Stewart

OncoGenex Pharmaceuticals

Chairman

News

You may also like